Literature DB >> 15107562

Antigenic differences between H5N1 human influenza viruses isolated in 1997 and 2003.

Taisuke Horimoto1, Nao Fukuda, Kiyoko Iwatsuki-Horimoto, Yi Guan, Wilina Lim, Malik Peiris, Shunji Sugii, Takato Odagiri, Masato Tashiro, Yoshihiro Kawaoka.   

Abstract

To assess whether the antigenic properties of H5 hemagglutinin (HA) change over time due to antigenic drift, we produced a panel of monoclonal antibodies (mAbs) against the HA of the index H5N1 human influenza A virus, A/Hong Kong/156/97. By immunizing mice with a plasmid expressing this HA and boosting the initial immunization with cell lysates transfected with the plasmid, a total of six hybridomas producing HA-specific mAbs were established: four to the HA1 subunit with hemadsorption-inhibiting activity and two to the HA2 subunit. None of the mAbs to HA1 could bind to the HA of a recent human isolate, A/Hong Kong/213/2003, indicating that there are substantial antigenic differences between the H5N1 human influenza virus isolated in 1997 and that isolated in 2003.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15107562     DOI: 10.1292/jvms.66.303

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  17 in total

1.  Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responses.

Authors:  Otfried Kistner; M Keith Howard; Martin Spruth; Walter Wodal; Peter Brühl; Marijan Gerencer; Brian A Crowe; Helga Savidis-Dacho; Ian Livey; Manfred Reiter; Ines Mayerhofer; Christa Tauer; Leopold Grillberger; Wolfgang Mundt; Falko G Falkner; P Noel Barrett
Journal:  Vaccine       Date:  2007-06-04       Impact factor: 3.641

2.  Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007.

Authors:  Wai Lan Wu; Yixin Chen; Pui Wang; Wenjun Song; Siu-Ying Lau; Jane M Rayner; Gavin J D Smith; Robert G Webster; J S Malik Peiris; Tianwei Lin; Ningshao Xia; Yi Guan; Honglin Chen
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

Review 3.  Innate immune evasion strategies of influenza viruses.

Authors:  Benjamin G Hale; Randy A Albrecht; Adolfo García-Sastre
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

Review 4.  Emerging respiratory viruses: challenges and vaccine strategies.

Authors:  Laura Gillim-Ross; Kanta Subbarao
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

5.  Characterization of a human H5N1 influenza A virus isolated in 2003.

Authors:  Kyoko Shinya; Masato Hatta; Shinya Yamada; Ayato Takada; Shinji Watanabe; Peter Halfmann; Taisuke Horimoto; Gabriele Neumann; Jin Hyun Kim; Wilina Lim; Yi Guan; Malik Peiris; Makoto Kiso; Takashi Suzuki; Yasuo Suzuki; Yoshihiro Kawaoka
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Potent monoclonal antibodies against Clostridium difficile toxin A elicited by DNA immunization.

Authors:  Chunhua Zhang; Ke Jin; Yanling Xiao; Ying Cheng; Zuhu Huang; Shixia Wang; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2013-07-12       Impact factor: 3.452

7.  Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic.

Authors:  David A Boltz; Bounlom Douangngeun; Phouvong Phommachanh; Settha Sinthasak; Ricarda Mondry; Caroline Obert; Patrick Seiler; Rachael Keating; Yasuo Suzuki; Hiroaki Hiramatsu; Elena A Govorkova; Robert G Webster
Journal:  J Gen Virol       Date:  2009-12-16       Impact factor: 3.891

8.  Protective memory responses are modulated by priming events prior to challenge.

Authors:  John A Rutigliano; Melissa Y Morris; Wen Yue; Rachael Keating; Richard J Webby; Paul G Thomas; Peter C Doherty
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

9.  Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.

Authors:  Laurel Yong-Hwa Lee; Do Lien Anh Ha; Cameron Simmons; Menno D de Jong; Nguyen Van Vinh Chau; Reto Schumacher; Yan Chun Peng; Andrew J McMichael; Jeremy J Farrar; Geoffrey L Smith; Alain R M Townsend; Brigitte A Askonas; Sarah Rowland-Jones; Tao Dong
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

10.  Development of mucosal adjuvants for intranasal vaccine for H5N1 influenza viruses.

Authors:  Hideki Hasegawa; Takeshi Ichinohe; Akira Ainai; Shin-Ichi Tamura; Takeshi Kurata
Journal:  Ther Clin Risk Manag       Date:  2009-03-26       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.